Index by author

01 August 2009; volume 34, issue 2

A

  1. Ackermann-Liebrich, U.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.

  2. Adler, D.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.

  3. Aliverti, A.

    1. Aliverti, A., M. Quaranta, and P. M. Calverley. " From the authors: ." European Respiratory Journal 34.2 (2009): 522. Web. 24 Feb. 2021.

  4. Ambrosino, N.

    1. Ambrosino, N., N. Carpenè, and M. Gherardi. "Chronic respiratory care for neuromuscular diseases in adults." European Respiratory Journal 34.2 (2009): 444-451. Web. 24 Feb. 2021.

  5. Annesi-Maesano, I.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.

  6. Ayres, J. G.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.
    2. Wood, A. M. et al "Outdoor air pollution is associated with disease severity in α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 346-353. Web. 24 Feb. 2021.

B

  1. Barbato, A.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.

  2. Battaile, J. T.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  3. Bertuola, F.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.

  4. Besozzi, G.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  5. Bevilacqua, N.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  6. Black, P. N.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.

  7. Blanc, F-X.

    1. Blanc, F-X. et al "Relaxation of tracheal smooth muscle is impaired in innate airway hyperresponsiveness." European Respiratory Journal 34.2 (2009): 417-424. Web. 24 Feb. 2021.

  8. Boersma, W. G.

    1. van der Eerden, M. M., and W. G. Boersma. "Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia." European Respiratory Journal 34.2 (2009): 521. Web. 24 Feb. 2021.

  9. Boonstra, A.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

  10. Boscardin, W. J.

    1. Cooper, C. B. et al "Treatment of mild persistent asthma by cutaneous electronic stimulation." European Respiratory Journal 34.2 (2009): 515-517. Web. 24 Feb. 2021.

  11. Bracke, K. R.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.

  12. Brand, P.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.

  13. Bridevaux, P-O.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.

  14. Brusasco, V.

    1. Brusasco, V.. "Statistically significant or clinically useful? From population studies to patient care." European Respiratory Journal 34.2 (2009): 291-292. Web. 24 Feb. 2021.

  15. Brusselle, G. G.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.

  16. Bush, A.

    1. Bush, A., and C. Hogg. "Many a slip?." European Respiratory Journal 34.2 (2009): 293-294. Web. 24 Feb. 2021.
    2. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.

C

  1. Calverley, P. M.

    1. Aliverti, A., M. Quaranta, and P. M. Calverley. " From the authors: ." European Respiratory Journal 34.2 (2009): 522. Web. 24 Feb. 2021.

  2. Carpenè, N.

    1. Ambrosino, N., N. Carpenè, and M. Gherardi. "Chronic respiratory care for neuromuscular diseases in adults." European Respiratory Journal 34.2 (2009): 444-451. Web. 24 Feb. 2021.

  3. Carré, P.

    1. Guilleminault, L., P. Carré, and P. Diot. "Hypersensitivity pneumonitis associated with temozolomide." European Respiratory Journal 34.2 (2009): 526. Web. 24 Feb. 2021.

  4. Centis, R.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  5. Chen, L.

    1. Dales, R. et al "Acute effects of outdoor air pollution on forced expiratory volume in 1 s: a panel study of schoolchildren with asthma." European Respiratory Journal 34.2 (2009): 316-323. Web. 24 Feb. 2021.

  6. Christmas, T.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.

  7. Coirault, C.

    1. Blanc, F-X. et al "Relaxation of tracheal smooth muscle is impaired in innate airway hyperresponsiveness." European Respiratory Journal 34.2 (2009): 417-424. Web. 24 Feb. 2021.

  8. Colthurst, J. R.

    1. Cooper, C. B. et al "Treatment of mild persistent asthma by cutaneous electronic stimulation." European Respiratory Journal 34.2 (2009): 515-517. Web. 24 Feb. 2021.

  9. Conradi, S. H.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  10. Cooper, C. B.

    1. Cooper, C. B. et al "Treatment of mild persistent asthma by cutaneous electronic stimulation." European Respiratory Journal 34.2 (2009): 515-517. Web. 24 Feb. 2021.

  11. Curjuric, I.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.

D

  1. Dales, R.

    1. Dales, R. et al "Acute effects of outdoor air pollution on forced expiratory volume in 1 s: a panel study of schoolchildren with asthma." European Respiratory Journal 34.2 (2009): 316-323. Web. 24 Feb. 2021.

  2. Dawson, A.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.

  3. de Miguel, J.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.

  4. Demoor, T.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.

  5. Demoule, A.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.

  6. Deslee, G.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  7. Dey, R.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.

  8. Dijkmans, B. A. C.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

  9. Diot, P.

    1. Guilleminault, L., P. Carré, and P. Diot. "Hypersensitivity pneumonitis associated with temozolomide." European Respiratory Journal 34.2 (2009): 526. Web. 24 Feb. 2021.

  10. Dratva, J.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.

  11. Drusano, G. L.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.

  12. Duguet, A.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.

E

  1. Ebi, K. L.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.

  2. Ekeowa, U. I.

    1. Gooptu, B., U. I. Ekeowa, and D. A. Lomas. "Mechanisms of emphysema in α1-antitrypsin deficiency: molecular and cellular insights." European Respiratory Journal 34.2 (2009): 475-488. Web. 24 Feb. 2021.

  3. Eker, B.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  4. El-Chemaly, S.

    1. El-Chemaly, S. et al "Statins in lymphangioleiomyomatosis: a word of caution." European Respiratory Journal 34.2 (2009): 513-514. Web. 24 Feb. 2021.

  5. Elewaut, D.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.

  6. Escarrabill, J.

    1. Escarrabill, J.. "Discharge planning and home care for end-stage COPD patients." European Respiratory Journal 34.2 (2009): 507-512. Web. 24 Feb. 2021.

  7. Esposito, S.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.

F

  1. Felber Dietrich, D.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.

  2. Forastiere, F.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.

  3. Forsberg, B.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.

  4. Frescura, A. M.

    1. Dales, R. et al "Acute effects of outdoor air pollution on forced expiratory volume in 1 s: a panel study of schoolchildren with asthma." European Respiratory Journal 34.2 (2009): 316-323. Web. 24 Feb. 2021.

  5. Fueki, M.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

  6. Fukuda, T.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

G

  1. Gamble, G. D.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.

  2. Garcia-Pachon, E.

    1. Garcia-Pachon, E.. "Paradoxical movement of the lower ribcage in COPD." European Respiratory Journal 34.2 (2009): 521-522. Web. 24 Feb. 2021.

  3. García de Pedro, J.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.

  4. Gaspoz, J-M.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.

  5. Gerbase, M. W.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.

  6. Gherardi, M.

    1. Ambrosino, N., N. Carpenè, and M. Gherardi. "Chronic respiratory care for neuromuscular diseases in adults." European Respiratory Journal 34.2 (2009): 444-451. Web. 24 Feb. 2021.

  7. Gierada, D. S.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  8. Girardi, E.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  9. Gonzalez-Bermejo, J.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.

  10. Gooptu, B.

    1. Gooptu, B., U. I. Ekeowa, and D. A. Lomas. "Mechanisms of emphysema in α1-antitrypsin deficiency: molecular and cellular insights." European Respiratory Journal 34.2 (2009): 475-488. Web. 24 Feb. 2021.

  11. Grünberg, K.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

  12. Guilleminault, L.

    1. Guilleminault, L., P. Carré, and P. Diot. "Hypersensitivity pneumonitis associated with temozolomide." European Respiratory Journal 34.2 (2009): 526. Web. 24 Feb. 2021.

H

  1. Haas, A. R.

    1. Haas, A. R.. " From the authors: ." European Respiratory Journal 34.2 (2009): 525. Web. 24 Feb. 2021.

  2. Hanna, K.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.

  3. Hansell, D. M.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.

  4. Harrison, N. K.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.

  5. Harrison, R. M.

    1. Wood, A. M. et al "Outdoor air pollution is associated with disease severity in α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 346-353. Web. 24 Feb. 2021.

  6. Heijdra, Y.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

  7. Helms, P. J.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.

  8. Herpich, C. H.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.

  9. Hill, A. T.

    1. Murray, M. P. et al "Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.2 (2009): 361-364. Web. 24 Feb. 2021.

  10. Hoffmann, H.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  11. Hogg, C.

    1. Bush, A., and C. Hogg. "Many a slip?." European Respiratory Journal 34.2 (2009): 293-294. Web. 24 Feb. 2021.

  12. Hogg, J. C.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  13. Holtzman, M. J.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  14. Hopkins, R. J.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.

  15. Hurbault, A.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.

I

  1. Irving, L. B.

    1. Steinfort, D. P., D. F. Johnson, and L. B. Irving. "Infective complications from endobronchial ultrasound-transbronchial needle aspiration." European Respiratory Journal 34.2 (2009): 524-525. Web. 24 Feb. 2021.

J

  1. Jenkins, G. H.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.

  2. Johnson, D. F.

    1. Steinfort, D. P., D. F. Johnson, and L. B. Irving. "Infective complications from endobronchial ultrasound-transbronchial needle aspiration." European Respiratory Journal 34.2 (2009): 524-525. Web. 24 Feb. 2021.

  3. Jones, R. M.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.

  4. Joos, G. F.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.

  5. Jorens, P. G.

    1. Jorens, P. G. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 34.2 (2009): 452-474. Web. 24 Feb. 2021.

K

  1. Kirsten, D.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  2. Kleerup, E. C.

    1. Cooper, C. B. et al "Treatment of mild persistent asthma by cutaneous electronic stimulation." European Respiratory Journal 34.2 (2009): 515-517. Web. 24 Feb. 2021.

  3. Klein, G.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.

  4. Korppi, M.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.

  5. Kotecha, S.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.

  6. Kuehni, C.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.

L

  1. Lange, C.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  2. Lecarpentier, Y.

    1. Blanc, F-X. et al "Relaxation of tracheal smooth muscle is impaired in innate airway hyperresponsiveness." European Respiratory Journal 34.2 (2009): 417-424. Web. 24 Feb. 2021.

  3. Leone, S.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.

  4. Le Pimpec-Barthes, F.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.

  5. Lewit, R. A.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  6. Liu, L.

    1. Dales, R. et al "Acute effects of outdoor air pollution on forced expiratory volume in 1 s: a panel study of schoolchildren with asthma." European Respiratory Journal 34.2 (2009): 316-323. Web. 24 Feb. 2021.
    2. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  7. Lomas, D. A.

    1. Gooptu, B., U. I. Ekeowa, and D. A. Lomas. "Mechanisms of emphysema in α1-antitrypsin deficiency: molecular and cellular insights." European Respiratory Journal 34.2 (2009): 475-488. Web. 24 Feb. 2021.

  8. Lucini, V.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.

M

  1. Ma, L.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.

  2. MacQuarrie, S.

    1. Murray, M. P. et al "Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.2 (2009): 361-364. Web. 24 Feb. 2021.

  3. Madsen, F.

    1. Madsen, F.. "Verification of equipment for measuring the diffusion capacity of the lung for carbon monoxide." European Respiratory Journal 34.2 (2009): 523-524. Web. 24 Feb. 2021.

  4. Maes, T.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.

  5. Martínez-Abad, Y.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.

  6. Massion, P. P.

    1. Ocak, S. et al "High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications." European Respiratory Journal 34.2 (2009): 489-506. Web. 24 Feb. 2021.

  7. Medina-Ramón, M.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.

  8. Metcalf, P.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.

  9. Meyer, T.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.

  10. Migliori, G. B.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  11. Milne, M.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  12. Mooi, W. J.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

  13. Moore, C. M.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  14. Morélot-Panzini, C.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.

  15. Moss, J.

    1. El-Chemaly, S. et al "Statins in lymphangioleiomyomatosis: a word of caution." European Respiratory Journal 34.2 (2009): 513-514. Web. 24 Feb. 2021.

  16. Murray, M. P.

    1. Murray, M. P. et al "Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.2 (2009): 361-364. Web. 24 Feb. 2021.

N

  1. Nicholson, A. G.

    1. Jones, R. M. et al "Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis." European Respiratory Journal 34.2 (2009): 517-520. Web. 24 Feb. 2021.

O

  1. O'Callaghan, C.

    1. Thomas, B., A. Rutman, and C. O'Callaghan. "Disrupted ciliated epithelium shows slower ciliary beat frequency and increased dyskinesia." European Respiratory Journal 34.2 (2009): 401-404. Web. 24 Feb. 2021.

  2. Ocak, S.

    1. Ocak, S. et al "High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications." European Respiratory Journal 34.2 (2009): 489-506. Web. 24 Feb. 2021.

  3. Okayama, Y.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

  4. Okumura, S.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

  5. Oliviero, P.

    1. Blanc, F-X. et al "Relaxation of tracheal smooth muscle is impaired in innate airway hyperresponsiveness." European Respiratory Journal 34.2 (2009): 417-424. Web. 24 Feb. 2021.

  6. Ortmann, J.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  7. Overbeek, M. J.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

P

  1. Pannacci, M.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.

  2. Parizel, P. M.

    1. Jorens, P. G. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 34.2 (2009): 452-474. Web. 24 Feb. 2021.

  3. Patterson, A.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  4. Pentland, J. L.

    1. Murray, M. P. et al "Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.2 (2009): 361-364. Web. 24 Feb. 2021.

  5. Pierce, J.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  6. Pierce, R. A.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

  7. Pijnenburg, M. W.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.

  8. Pilette, C.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.

  9. Postmus, P. E.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

  10. Probst-Hensch, N. M.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.

  11. Puente-Maestu, L.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.

Q

  1. Quaranta, M.

    1. Aliverti, A., M. Quaranta, and P. M. Calverley. " From the authors: ." European Respiratory Journal 34.2 (2009): 522. Web. 24 Feb. 2021.

R

  1. Ra, C.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

  2. Ratjen, F.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.

  3. Richardson, M. D.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  4. Rochat, T.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.

  5. Rutman, A.

    1. Thomas, B., A. Rutman, and C. O'Callaghan. "Disrupted ciliated epithelium shows slower ciliary beat frequency and increased dyskinesia." European Respiratory Journal 34.2 (2009): 401-404. Web. 24 Feb. 2021.

S

  1. Sagara, H.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

  2. Saito, H.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

  3. Sanz, M. L.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.

  4. Sanz, P.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.

  5. Sasaki, T.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

  6. Scaglione, F.

    1. Scaglione, F. et al "Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia." European Respiratory Journal 34.2 (2009): 394-400. Web. 24 Feb. 2021.

  7. Schindler, C.

    1. Bridevaux, P-O. et al "Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2." European Respiratory Journal 34.2 (2009): 332-339. Web. 24 Feb. 2021.

  8. Schulte, M.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.

  9. Seddon, P.

    1. Barbato, A. et al "Paediatrics in Berlin." European Respiratory Journal 34.2 (2009): 436-443. Web. 24 Feb. 2021.

  10. Semple, S.

    1. Wood, A. M. et al "Outdoor air pollution is associated with disease severity in α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 346-353. Web. 24 Feb. 2021.

  11. Siafakas, N. M.

    1. Tzortzaki, E. G., and N. M. Siafakas. "A hypothesis for the initiation of COPD." European Respiratory Journal 34.2 (2009): 310-315. Web. 24 Feb. 2021.

  12. Similowski, T.

    1. Adler, D. et al "Diaphragm pacing restores olfaction in tetraplegia." European Respiratory Journal 34.2 (2009): 365-370. Web. 24 Feb. 2021.

  13. Simonds, A. K.

    1. Simonds, A. K., and D. K. Sokol. "Lives on the line? Ethics and practicalities of duty of care in pandemics and disasters." European Respiratory Journal 34.2 (2009): 303-309. Web. 24 Feb. 2021.

  14. Skrahina, A.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  15. Smit, E. F.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

  16. Snoeckx, A.

    1. Jorens, P. G. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 34.2 (2009): 452-474. Web. 24 Feb. 2021.

  17. Sokol, D. K.

    1. Simonds, A. K., and D. K. Sokol. "Lives on the line? Ethics and practicalities of duty of care in pandemics and disasters." European Respiratory Journal 34.2 (2009): 303-309. Web. 24 Feb. 2021.

  18. Sos, M. L.

    1. Ocak, S. et al "High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications." European Respiratory Journal 34.2 (2009): 489-506. Web. 24 Feb. 2021.

  19. Sotgiu, G.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.

  20. Steinfort, D. P.

    1. Steinfort, D. P., D. F. Johnson, and L. B. Irving. "Infective complications from endobronchial ultrasound-transbronchial needle aspiration." European Respiratory Journal 34.2 (2009): 524-525. Web. 24 Feb. 2021.

  21. Stockley, R. A.

    1. Wood, A. M. et al "Outdoor air pollution is associated with disease severity in α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 346-353. Web. 24 Feb. 2021.

  22. Stringer, W. W.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.

  23. Stylianou, M. P.

    1. El-Chemaly, S. et al "Statins in lymphangioleiomyomatosis: a word of caution." European Respiratory Journal 34.2 (2009): 513-514. Web. 24 Feb. 2021.

  24. Sugiyama, K.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

T

  1. Takeda, K.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

  2. Taveira-DaSilva, A.

    1. El-Chemaly, S. et al "Statins in lymphangioleiomyomatosis: a word of caution." European Respiratory Journal 34.2 (2009): 513-514. Web. 24 Feb. 2021.

  3. Thomas, B.

    1. Thomas, B., A. Rutman, and C. O'Callaghan. "Disrupted ciliated epithelium shows slower ciliary beat frequency and increased dyskinesia." European Respiratory Journal 34.2 (2009): 401-404. Web. 24 Feb. 2021.

  4. Thomas, R. K.

    1. Ocak, S. et al "High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications." European Respiratory Journal 34.2 (2009): 489-506. Web. 24 Feb. 2021.

  5. Turnbull, K.

    1. Murray, M. P. et al "Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis." European Respiratory Journal 34.2 (2009): 361-364. Web. 24 Feb. 2021.

  6. Tzortzaki, E. G.

    1. Tzortzaki, E. G., and N. M. Siafakas. "A hypothesis for the initiation of COPD." European Respiratory Journal 34.2 (2009): 310-315. Web. 24 Feb. 2021.

V

  1. van der Eerden, M. M.

    1. van der Eerden, M. M., and W. G. Boersma. "Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia." European Respiratory Journal 34.2 (2009): 521. Web. 24 Feb. 2021.

  2. Vandooren, B.

    1. Demoor, T. et al "Role of lymphotoxin-α in cigarette smoke-induced inflammation and lymphoid neogenesis." European Respiratory Journal 34.2 (2009): 405-416. Web. 24 Feb. 2021.

  3. Van Marck, E.

    1. Jorens, P. G. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 34.2 (2009): 452-474. Web. 24 Feb. 2021.

  4. Villar, F.

    1. Puente-Maestu, L. et al "Clinical relevance of constant power exercise duration changes in COPD." European Respiratory Journal 34.2 (2009): 340-345. Web. 24 Feb. 2021.

  5. Villeneuve, P. J.

    1. Dales, R. et al "Acute effects of outdoor air pollution on forced expiratory volume in 1 s: a panel study of schoolchildren with asthma." European Respiratory Journal 34.2 (2009): 316-323. Web. 24 Feb. 2021.

  6. Vonk, M. C.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

  7. Vonk-Noordegraaf, A.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

  8. Voskuyl, A. E.

    1. Overbeek, M. J. et al "Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy." European Respiratory Journal 34.2 (2009): 371-379. Web. 24 Feb. 2021.

W

  1. Watanabe, N.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

  2. Wencker, M.

    1. Brand, P. et al "Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 354-360. Web. 24 Feb. 2021.

  3. Windt, M.

    1. Ayres, J. G. et al "Climate change and respiratory disease: European Respiratory Society position statement." European Respiratory Journal 34.2 (2009): 295-302. Web. 24 Feb. 2021.

  4. Wood, A. M.

    1. Wood, A. M. et al "Outdoor air pollution is associated with disease severity in α1-antitrypsin deficiency." European Respiratory Journal 34.2 (2009): 346-353. Web. 24 Feb. 2021.

  5. Woods, J. C.

    1. Deslee, G. et al "Elastin expression in very severe human COPD." European Respiratory Journal 34.2 (2009): 324-331. Web. 24 Feb. 2021.

Y

  1. Young, R. P.

    1. Young, R. P. et al "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history." European Respiratory Journal 34.2 (2009): 380-386. Web. 24 Feb. 2021.

  2. Yuki, K.

    1. Okayama, Y. et al "FcϵRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells." European Respiratory Journal 34.2 (2009): 425-435. Web. 24 Feb. 2021.

Z

  1. Zellweger, J-P.

    1. Migliori, G. B. et al "A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis." European Respiratory Journal 34.2 (2009): 387-393. Web. 24 Feb. 2021.
Back to top
European Respiratory Journal: 34 (2)

Search Within This Issue

Jump to

Manage Table of content Alerts